This Week at the FDA: New CDER Director, End of the Shutdown, and MoreNovember 14, 2025November 20, 2025
This Week at FDA: More Layoffs at HHS, Prasad’s CBER Hires, and Peter Marks Joins Eli LillyOctober 10, 2025October 14, 2025
FDA Announces New ANDA Prioritization Pilot to Support U.S. Generic Drug Manufacturing and TestingOctober 3, 2025October 4, 2025
This Week at FDA: ANDA Prioritization Pilot, CDRH Guidance Priorities, and MoreOctober 3, 2025October 4, 2025
FDA Approves Generic Abortion Pill as Opponents Push Trump for New RestrictionsOctober 2, 2025October 4, 2025
FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug DevelopmentOctober 1, 2025October 14, 2025
What Trump’s new Tariffs Mean for Pharmaceuticals and Patented DrugsSeptember 26, 2025September 29, 2025
